These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 356352)

  • 1. Immunosuppressive activity of carrageenan for cell-mediated responses in the mouse.
    Rumjanek VM; Brent L
    Transplantation; 1978 Aug; 26(2):113-8. PubMed ID: 356352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrageenan: a review of its effects on the immune system.
    Thomson AW; Fowler EF
    Agents Actions; 1981 May; 11(3):265-73. PubMed ID: 7020378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.
    Herberman RB; Nunn ME; Holden HT; Lavrin DH
    Int J Cancer; 1975 Aug; 16(2):230-9. PubMed ID: 1080480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrageenan and the immune response.
    Thomson AW
    Biomedicine; 1978; 28(3):148-52. PubMed ID: 359059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carrageenan on the induction of cell-mediated cytotoxic responses in vivo.
    Sakemi T; Kuroiwa A; Nomoto K
    Immunology; 1980 Oct; 41(2):297-302. PubMed ID: 6969217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of carrageenan on the non-specific resistance of mice to injected syngeneic tumour cells, alone or in mixtures.
    Wu RL; Kearney R
    Br J Cancer; 1979 Mar; 39(3):241-6. PubMed ID: 465296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of lymphocyte responsiveness in vitro by lambda carrageenan compared with colloidal silica and depletion of surface adherent cells.
    Pawelec G; Brons G
    Clin Exp Immunol; 1978 Mar; 31(3):426-35. PubMed ID: 207475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a novel immunosuppressant, FTY720, in mice without secondary lymphoid organs.
    Sugito K; Koshinaga T; Inoue M; Ikeda T; Hagiwara N; Fukuzawa M
    Surg Today; 2005; 35(8):662-7. PubMed ID: 16034547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of carrageenan as an immunosuppressive agent and mediator of intravascular coagulation.
    Thomson AW; Wilson AR; Cruickshank WJ; Horne CH
    Biomedicine; 1976 May; 24(2):102-6. PubMed ID: 776242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carrageenan, PVP and tumour-bearer serum on immunity induced by excision or mitomycin C-treated tumour cells in mice.
    Kearney R; Wu RL; Orr F
    Br J Cancer; 1979 Jun; 39(6):648-58. PubMed ID: 444404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asialo GM1 positive CD8+ T cells induce skin allograft rejection in the absence of the secondary lymphoid organs.
    Yamanokuchi S; Ikai I; Nishitai R; Matsushita T; Sugimoto S; Shiotani T; Yamaoka Y
    J Surg Res; 2005 Nov; 129(1):57-63. PubMed ID: 16140338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A re-evaluation of the role of macrophages in carrageenan-induced immunosuppression.
    Rumjanek VM; Watson SR; Sljivić VS
    Immunology; 1977 Sep; 33(3):423-32. PubMed ID: 332622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of carrageenan-induced immune suppression with alleviation of toxicity in aprotinin-treated mice.
    Fowler EF; Thomson AW
    Int J Immunopharmacol; 1979; 1(1):69-72. PubMed ID: 95188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-mediated suppression of T lymphocyte proliferation induced by oral carrageenan administration.
    Cochran FR; Baxter CS
    Immunology; 1984 Oct; 53(2):291-7. PubMed ID: 6237983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
    Milas L; Basic I; Kogelnik HD; Withers HR
    Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective lymphoid irradiation. VI. Effect of palladium-109-labeled lymphocytes on rat cardiac allograft survival.
    Oluwole S; Fawwaz R; Kuromoto N; Reemtsma K; Hardy MA
    Transplantation; 1985 Aug; 40(2):146-50. PubMed ID: 3895619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotoxin from Naja naja atra venom inhibits skin allograft rejection in rats.
    Xu YL; Kou JQ; Wang SZ; Chen CX; Qin ZH
    Int Immunopharmacol; 2015 Sep; 28(1):188-98. PubMed ID: 26071222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.